Potent activity of polymyxin B is associated with long-lived super-stoichiometric accumulation mediated by

Kerry R Buchholz1, Mike Reichelt2, Matthew C Johnson3

  • 1Department of Infectious Diseases, Genentech, Inc., South San Francisco, CA, USA. buchholz.kerry@gene.com.

PubMed

Insights

Polymyxins, crucial gram-negative antibiotics, bind lipid A in a three-state process: transient binding, insertion, and accumulation. This mechanism explains their membrane permeabilization and bactericidal activity, guiding new antibiotic discovery.

Area of Science:

  • Microbiology
  • Biochemistry
  • Pharmacology

Background:

  • Polymyxins are vital antibiotics for treating gram-negative bacterial infections.
  • Their precise molecular mechanisms of action, particularly interactions with lipid A, are not fully understood.
  • Lipid A is the essential membrane anchor of lipopolysaccharide in the outer membrane of gram-negative bacteria.

Purpose of the Study:

  • To elucidate the kinetic and mechanistic details of polymyxin interactions with lipid A.
  • To develop a phenomenological model describing polymyxin binding and activity.
  • To identify key molecular events that lead to polymyxin's bactericidal effects.

Main Methods:

  • Surface plasmon resonance (SPR) was employed to kinetically analyze polymyxin-lipid A interactions.
  • A phenomenological model was derived from the kinetic data.
  • Interactions of brevicidine and polymyxin-resistant lipid A mutants were also studied.

Main Results:

  • Polymyxins interact with lipid A via a three-state mechanism: transient binding, membrane insertion, and super-stoichiometric cluster accumulation with long residence times.
  • Brevicidine, another lipid A-targeting molecule, also showed accumulation.
  • Polymyxin resistance mutations and a non-bactericidal derivative impaired the transition to long-lived species.

Conclusions:

  • The proposed three-state mechanism, involving transient binding for outer membrane permeabilization and cluster accumulation for bactericidal activity, explains polymyxin action.
  • These findings provide a framework for designing novel lipid A-targeting antibiotics.
  • The study offers a generalizable method for investigating interactions with the gram-negative outer membrane.

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.8K
Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism01:21

Factors Affecting Dissolution: Polymorphism, Amorphism and Pseudopolymorphism

Polymorphism refers to the existence of a drug substance in multiple crystalline forms, known as polymorphs. Recently, this term has been expanded to include solvates (forms containing a solvent), amorphous forms (non-crystalline forms), and desolvated solvates (forms from which the solvent has been removed).
Some polymorphic crystals possess lower aqueous solubility than their amorphous counterparts, leading to incomplete absorption. For instance, the oral suspension of Chloramphenicol, which...
299
Factors Affecting Protein-Drug Binding: Drug-Related Factors01:18

Factors Affecting Protein-Drug Binding: Drug-Related Factors

Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
96
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
2.6K
Factors Affecting Protein-Drug Binding: Protein-Related Factors01:20

Factors Affecting Protein-Drug Binding: Protein-Related Factors

Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...
150
Antimicrobial Proteins01:23

Antimicrobial Proteins

Antimicrobial proteins are important components of the immune system. They aid the body in combating pathogens by either killing them directly or hindering their replication processes. Four main types of antimicrobial substances are interferons, the complement system, iron-binding proteins, and antimicrobial proteins.
Interferons
Interferons (IFNs) are proteins produced by lymphocytes, macrophages, and fibroblasts infected with viruses. While IFNs cannot prevent viruses from entering and...
979